Prognostic Features of Anti-Cancer Drugs Response in Resected/Unresected Primary Non-Small Cell Lung Cancer: A Retrospective Cohort Study
This retrospective cohort study of 2,459 NSCLC patients identifies that low chemotherapy prescription frequency correlates with poor survival and non-response, while highlighting pre-chemotherapy leukocytosis as a negative prognostic factor and oral receptor tyrosine kinase inhibitors as an effective alternative for non-responders.